DK1392248T3 - Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat - Google Patents

Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat

Info

Publication number
DK1392248T3
DK1392248T3 DK02730275T DK02730275T DK1392248T3 DK 1392248 T3 DK1392248 T3 DK 1392248T3 DK 02730275 T DK02730275 T DK 02730275T DK 02730275 T DK02730275 T DK 02730275T DK 1392248 T3 DK1392248 T3 DK 1392248T3
Authority
DK
Denmark
Prior art keywords
preparation
implants
solvent
homogenate
free
Prior art date
Application number
DK02730275T
Other languages
Danish (da)
English (en)
Inventor
Gregor Schuetz
Brigitte Freudensprung
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26009392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1392248(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001125509 external-priority patent/DE10125509A1/de
Priority claimed from DE2002108382 external-priority patent/DE10208382A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK1392248T3 publication Critical patent/DK1392248T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK02730275T 2001-05-23 2002-05-23 Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat DK1392248T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001125509 DE10125509A1 (de) 2001-05-23 2001-05-23 Lösungsmittelfreie Homogenisatherstellung
DE2002108382 DE10208382A1 (de) 2002-02-27 2002-02-27 Homogenisat für Implantate und Mikropartikel
PCT/EP2002/005680 WO2002094226A1 (de) 2001-05-23 2002-05-23 Homogenisat für implantate und mikropartikel

Publications (1)

Publication Number Publication Date
DK1392248T3 true DK1392248T3 (da) 2007-11-12

Family

ID=26009392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02730275T DK1392248T3 (da) 2001-05-23 2002-05-23 Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat

Country Status (16)

Country Link
US (1) US8501056B2 (es)
EP (1) EP1392248B1 (es)
JP (1) JP4346909B2 (es)
AT (1) ATE369122T1 (es)
BR (1) BR0209914A (es)
CA (1) CA2449502C (es)
CY (1) CY1106944T1 (es)
CZ (1) CZ20033160A3 (es)
DE (1) DE50210646D1 (es)
DK (1) DK1392248T3 (es)
ES (1) ES2290294T3 (es)
NO (1) NO20035179D0 (es)
PL (1) PL364054A1 (es)
PT (1) PT1392248E (es)
SK (1) SK14182003A3 (es)
WO (1) WO2002094226A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE369122T1 (de) 2001-05-23 2007-08-15 Hexal Ag Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
FR2879074B1 (fr) * 2004-12-15 2007-08-03 Adisseo France Sas Soc Par Act Granules de principe actif hydrophile
FR2879075B1 (fr) * 2004-12-15 2007-01-19 Adisseo France Sas Soc Par Act Procede de preparation de granules de principe actif hydrophile par extrusion
CN101095941B (zh) * 2006-06-29 2011-04-20 北京博恩特药业有限公司 醋酸亮丙瑞林在预防和治疗老年性骨质疏松中的新用途
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
WO2013065664A1 (ja) * 2011-10-31 2013-05-10 花王株式会社 化粧料
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
WO2016076800A1 (en) * 2014-11-14 2016-05-19 Nanyang Technological University Bioresorbable-magnesium composite
USD782771S1 (en) 2015-04-03 2017-03-28 Geo Plastics Tight head drum
EP3492070A1 (en) 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion
USD938128S1 (en) 2020-01-06 2021-12-07 Geo Plastics Nestable drum
USD1001413S1 (en) 2020-06-30 2023-10-10 Geo Plastics Nestable drum

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992350A (en) * 1972-05-04 1976-11-16 Produits Chimiques Ugine Kuhlmann Process of mixing fillers with polytetrafluorethylene and tetrafluorethylene copolymers
US4016345A (en) * 1972-12-22 1977-04-05 E. I. Du Pont De Nemours And Company Process for polymerizing tetrafluoroethylene in aqueous dispersion
FR2418067A1 (fr) 1978-02-22 1979-09-21 Omya Sa Procede pour incorporer a un polymere des additifs solides, liquides ou pateux a temperature ambiante
DE3865133D1 (de) * 1987-07-10 1991-10-31 Karl Reinhard Zeiss Verfahren zur herstellung und zur verarbeitung von reaktionskunststoff-mischungen.
US4917834A (en) * 1988-11-16 1990-04-17 General Technology Applications, Inc. Method for forming homogeneous blends of particulate materials
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (es) * 1989-07-28 1992-01-15 Debiopharm Sa
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
US5456917A (en) 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE19545327C2 (de) * 1995-12-05 2001-04-19 Fraunhofer Ges Forschung Verfahren zur Herstellung von hydrophobierten resorbierbaren Polyestern und deren Verwendung
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US6177609B1 (en) * 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
CA2301304A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
ID28909A (id) 1998-12-16 2001-07-12 Aventis Pharma Inc Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
ATE369122T1 (de) 2001-05-23 2007-08-15 Hexal Ag Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
US6712850B2 (en) * 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US6894088B2 (en) * 2003-03-24 2005-05-17 Baker Hughes Incorporated Process for homogenizing polyolefin drag reducing agents

Also Published As

Publication number Publication date
NO20035179D0 (no) 2003-11-21
JP4346909B2 (ja) 2009-10-21
CA2449502C (en) 2010-10-12
SK14182003A3 (sk) 2004-05-04
EP1392248B1 (de) 2007-08-08
PL364054A1 (en) 2004-12-13
PT1392248E (pt) 2007-10-11
ATE369122T1 (de) 2007-08-15
ES2290294T3 (es) 2008-02-16
BR0209914A (pt) 2004-04-06
US20040173923A1 (en) 2004-09-09
JP2004530696A (ja) 2004-10-07
CZ20033160A3 (en) 2004-03-17
US8501056B2 (en) 2013-08-06
CA2449502A1 (en) 2002-11-28
DE50210646D1 (de) 2007-09-20
CY1106944T1 (el) 2012-09-26
EP1392248A1 (de) 2004-03-03
WO2002094226A1 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
CY1106944T1 (el) Μεθοδος για την παραγωγη εμφυτευματων μεσω παραγωγης - ανευ διαλυτων - ενος προϊοντος ομογενοποιησης
AU2002366083A1 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
EP1957256A4 (en) PROCESS FOR SOLVING A POLYOLEFIN CLASS POLYMER PREPARATION FOR ELECTROSPINNING PROCESSING
WO2005074619A3 (en) Highly crystalline cross-linked oxidation-resistant polyethylene
DE60237986D1 (de) Polymer auf basis von konjugierten dienen, herstellungsverfahren dafür und dieses enthaltende kautschukzusammensetzungen
BR0209810A (pt) Composição de polìmero misturada por fusão, método de preparação de implantes, e, implante formado a partir de uma composição de polìmero misturada por fusão
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE60011243D1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
WO2007078427A3 (en) Diffusion-hardened medical implant
BR0106838B1 (pt) método de sintetizar uma mistura de polìmeros, e, mistura de polìmeros.
ATE471924T1 (de) 3-alkyl-5,5',6,6',7,7',8,8'-octahydro-2,2'- binaphthole und 3,3'-dialkyl-5,5',6,6',7,7',8,8'- octahydro-2,2'-binaphthole, sowie verfahren zur ihrer herstellung
ATE551046T1 (de) Polymere duftkapseln und ihre herstellung
WO2003047646A8 (en) Resorbable polymer composition, implant and method of making implant
DE60117414D1 (de) Methode zur herstellung lycopen-konzentrats frei von organischen lösungsmitteln, das resultierende konzentrat und dieses konzentrat enthaltende zusammensetzungen
ATE357469T1 (de) Sterilisierende polymere und deren herstellung und verwendung
BRPI0416672A (pt) método de produção de uma composição granular contendo lecitina e composição granular contendo lecitina
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
NO20034278L (no) Sammensetninger og fremgangsmåter til behandling av HCV- infeksjoner
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
DE60330099D1 (de) Verfahren und Anordnungen zur Herstellung, Feststellung und Übertragung von Identifikatoren
DE60204464D1 (de) Verfahren zur herstellung von ethern, vorzugsweise von thf
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE507200T1 (de) Klare photopolymerisierbare systeme zur herstellung von beschichtungen grosser dicke